Drug intelligence / Profile preview

vitamin e + silymarin + carnitine

Development stage
Unknown
Lead developer
BioVie
Modality
Small Molecules
Administration
Oral
01

Overview

Vitamin E + silymarin + carnitine is a combination antioxidant and metabolic supplement, often abbreviated as VSC, studied for the treatment of nonalcoholic fatty liver disease (NAFLD), metabolic syndrome, and type 2 diabetes. The formulation typically comprises 200 IU of vitamin E, 750 mg of silymarin, and 1 gram of L-carnitine. It exerts its therapeutic effects through synergistic antioxidant and anti-inflammatory mechanisms, which help reduce markers of liver inflammation (such as ALT and AST), improve insulin sensitivity, and lower triglyceride levels. Clinical research, including studies associated with Biovil Corporation, has evaluated the efficacy of this three-component combination in improving hepatic function and metabolic parameters.

Other names
VSCvitamin E/silymarin/L-carnitine combination
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))SLC7A1 (Cationic amino acid transporter 1)

Beyond the preview

Go deeper on vitamin e + silymarin + carnitine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on vitamin e + silymarin + carnitine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call